Everest Medicines Ltd - 05 Aug 2025 SCHEDULE 13D Report for I-MAB Ordinary shares, par value US$0.0001 per share (IMAB)

Filing Manager: Everest Medicines Ltd
Reporting Manager: Everest Medicines Limited
Security: I-MAB Ordinary shares, par value US$0.0001 per share
Symbol: IMAB
Shares outstanding: 264,128,671 shares
Disclosed Ownership: 42,524,716 shares
Ownership: 16.1%
Form type: SCHEDULE 13D
Filing time: 05 Aug 2025, 16:00:08 UTC
Date of event: 05 Aug 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Everest Medicines Limited	16.1%	42,524,716	42,524,716	0	/s/ Ian Ying WOO	Ian Ying WOO, CFO&President	0001783937